CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Adefovir

阿德福韦 杂质对照品Adefovir Impurities

48 个杂质条目48 impurity entries

本页汇总 阿德福韦 的 48 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 48 impurity reference standards of Adefovir. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿德福韦(Adefovir)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA Simple and Specific Stability- Indicating RP-HPLC Method for Routine Assay of Adefovir Dipivoxil in Bulk and Tablet Dosage Form
    Iranian journal of pharmaceutical research : IJPR · 2017 · Darsazan B et al.  ·  PMID 28496468
  2. 杂质研究Impurity studiesMechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2016 · Lin RZ et al.  ·  PMID 26462447  ·  DOI
  3. 杂质研究Impurity studies[Determination of adefovir dipivoxil and its degradation products by reversed-phase high performance liquid chromatography]
    Se pu = Chinese journal of chromatography · 2004 · Jiang Y et al.  ·  PMID 15712909
  4. 分析方法Analytical MethodsDevelopment and Validation of a Sensitive LC-MS-MS Method for the Determination of Adefovir in Human Serum and Urine: Application to a Clinical Pharmacokinetic Study
    Journal of chromatographic science · 2016 · Zhang Y et al.  ·  PMID 26657410  ·  DOI
  5. 分析方法Analytical MethodsVoltammetric quantification of anti-hepatitis drug Adefovir in biological matrix and pharmaceutical formulation
    Journal of pharmaceutical analysis · 2012 · Jain R, Sharma R  ·  PMID 29403728  ·  DOI

阿德福韦 —— 原料药与杂质对照品Adefovir — drug substance & impurities

共 49 个条目(含原料药本体)49 items incl. the drug substance
Adefovir structure
原料药 APIAPI
阿德福韦Adefovir
Adefovir
CAS No.106941-25-7
Chemical FormulaC8H12N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity A Lactose adduct structure
A
Adefovir Dipivoxil Impurity A Lactose adduct
CAS No.—
Chemical FormulaC26H42N5O16P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil structure
—
阿德福韦杂质3Adefovir Dipivoxil
Adefovir Dipivoxil
CAS No.142340-99-6
Chemical FormulaC20H32N5O8P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Disoproxil Dimer Impurity structure
—
Adefovir Disoproxil Dimer Impurity
CAS No.—
Chemical FormulaC39H60N10O20P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Lactose adduct structure
—
Adefovir Dipivoxil Lactose adduct
CAS No.—
Chemical FormulaC32H52N5O18P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Trimer structure
—
Adefovir Dipivoxil Trimer
CAS No.—
Chemical FormulaC62H96N15O24P3
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 1 structure
1
阿德福韦杂质20Adefovir Dipivoxil Impurity 1
Adefovir Dipivoxil Impurity 1
CAS No.1215101-40-8
Chemical FormulaC25H40N5O9P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 2 structure
2
阿德福韦杂质19Adefovir Dipivoxil Impurity 2
Adefovir Dipivoxil Impurity 2
CAS No.1416439-02-5
Chemical FormulaC19H30N5O7P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 3 structure
3
阿德福韦杂质9Adefovir Dipivoxil Impurity 3
Adefovir Dipivoxil Impurity 3
CAS No.323201-06-5
Chemical FormulaC29H44N10O12P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 4 structure
4
Adefovir Dipivoxil Impurity 4
CAS No.—
Chemical FormulaC35H54N10O14P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 5 structure
5
阿德福韦杂质5Adefovir Impurity 5
Adefovir Impurity 5
CAS No.707-99-3
Chemical FormulaC7H9N5O
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 5 structure
5
Adefovir Dipivoxil Impurity 5
CAS No.—
Chemical FormulaC15H24N5O7P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 6 structure
6
阿德福韦杂质6Adefovir Impurity 6
Adefovir Impurity 6
CAS No.31618-90-3
Chemical FormulaC12H19O6PS
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 6 structure
6
Adefovir Dipivoxil Impurity 6
CAS No.—
Chemical FormulaC9H15N5O7P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 7 structure
7
阿德福韦杂质7Adefovir Impurity 7
Adefovir Impurity 7
CAS No.116384-53-3
Chemical FormulaC12H20N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 7 structure
7
Adefovir Dipivoxil Impurity 7
CAS No.—
Chemical FormulaC9H15N5O7P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 8 structure
8
Adefovir Dipivoxil Impurity 8
CAS No.—
Chemical FormulaC26H42N5O10P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 9 structure
9
Adefovir Dipivoxil Impurity 9
CAS No.—
Chemical FormulaC60H92N15O24P3
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 10 (Mono-POM Methyl Adefovir) structure
10
阿德福韦杂质21Adefovir Dipivoxil Impurity 10 (Mono-POM Methyl Adefovir)
Adefovir Dipivoxil Impurity 10 (Mono-POM Methyl Adefovir)
CAS No.1875153-79-9
Chemical FormulaC15H24N5O6P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 11 Potassium Salt structure
11
阿德福韦杂质11钾盐Adefovir Impurity 11 Potassium Salt
Adefovir Impurity 11 Potassium Salt
CAS No.10519-96-7
Chemical FormulaC3H9KOSi
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 11 structure
11
阿德福韦杂质11Adefovir Impurity 11
Adefovir Impurity 11
CAS No.1066-40-6
Chemical FormulaC3H10OSi
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 12 structure
12
阿德福韦杂质12Adefovir Impurity 12
Adefovir Impurity 12
CAS No.105-60-2
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 12 structure
12
阿德福韦杂质8Adefovir Dipivoxil Impurity 12
Adefovir Dipivoxil Impurity 12
CAS No.20245-85-6
Chemical FormulaC7H7N5
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 13 structure
13
阿德福韦杂质13Adefovir Impurity 13
Adefovir Impurity 13
CAS No.18997-19-8
Chemical FormulaC6H11ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 13 structure
13
阿德福韦杂质30Adefovir Dipivoxil Impurity 13
Adefovir Dipivoxil Impurity 13
CAS No.91240-66-3
Chemical FormulaC9H13N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 14 structure
14
阿德福韦杂质31Adefovir Dipivoxil Impurity 14
Adefovir Dipivoxil Impurity 14
CAS No.4551-95-5
Chemical FormulaC7H9N5O
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 15 (Pivalic Anhydride) structure
15
阿德福韦杂质36Adefovir Dipivoxil Impurity 15 (Pivalic Anhydride)
Adefovir Dipivoxil Impurity 15 (Pivalic Anhydride)
CAS No.1538-75-6
Chemical FormulaC10H18O3
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 16 structure
16
阿德福韦杂质32Adefovir Dipivoxil Impurity 16
Adefovir Dipivoxil Impurity 16
CAS No.116384-54-4
Chemical FormulaC10H16N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 17 structure
17
Adefovir Dipivoxil Impurity 17
CAS No.—
Chemical FormulaC20H32N5O8P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 18 structure
18
Adefovir Dipivoxil Impurity 18
CAS No.—
Chemical FormulaC32H52N5O18P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 19 structure
19
阿德福韦杂质25Adefovir Dipivoxil Impurity 19
Adefovir Dipivoxil Impurity 19
CAS No.142341-05-7
Chemical FormulaC14H22N5O6P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 20 structure
20
阿德福韦杂质2Adefovir Dipivoxil Impurity 20
Adefovir Dipivoxil Impurity 20
CAS No.323201-05-4
Chemical FormulaC41H64N10O16P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 21 structure
21
阿德福韦杂质22Adefovir Dipivoxil Impurity 21
Adefovir Dipivoxil Impurity 21
CAS No.142341-04-6
Chemical FormulaC16H26N5O6P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Dipivoxil Impurity 22 (Adefovir Dipivoxyl N6-Hydroxymethyl Impurity) structure
22
阿德福韦杂质1Adefovir Dipivoxil Impurity 22 (Adefovir Dipivoxyl N6-Hydroxymethyl Impurity)
Adefovir Dipivoxil Impurity 22 (Adefovir Dipivoxyl N6-Hydroxymethyl Impurity)
CAS No.323201-04-3
Chemical FormulaC21H34N5O9P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 24 structure
24
阿德福韦杂质24Adefovir Impurity 24
Adefovir Impurity 24
CAS No.1215101-42-0
Chemical FormulaC35H54N10O14P2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 29 structure
29
阿德福韦杂质29Adefovir Impurity 29
Adefovir Impurity 29
CAS No.2868360-26-1
Chemical FormulaC32H52N5O18P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 34 structure
34
阿德福韦杂质34Adefovir Impurity 34
Adefovir Impurity 34
CAS No.260252-89-9
Chemical FormulaC3H9O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 40 structure
40
阿德福韦杂质40Adefovir Impurity 40
Adefovir Impurity 40
CAS No.24630-67-9
Chemical FormulaC3H9O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 42 structure
42
阿德福韦杂质42Adefovir Impurity 42
Adefovir Impurity 42
CAS No.3277-26-7
Chemical FormulaC4H14OSi2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 43 structure
43
阿德福韦杂质43Adefovir Impurity 43
Adefovir Impurity 43
CAS No.1346603-45-9
Chemical FormulaC8H13N5O7P2·n(C6H15N)
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 44 structure
44
阿德福韦杂质44Adefovir Impurity 44
Adefovir Impurity 44
CAS No.1346598-45-5
Chemical FormulaC8H14N5O10P3·n(C6H15N)
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 45 structure
45
阿德福韦杂质45Adefovir Impurity 45
Adefovir Impurity 45
CAS No.2891863-11-7
Chemical FormulaC10H16N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 49 structure
49
阿德福韦杂质49Adefovir Impurity 49
Adefovir Impurity 49
CAS No.132255-83-5
Chemical FormulaC8H21NOSi2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 51 structure
51
阿德福韦杂质51Adefovir Impurity 51
Adefovir Impurity 51
CAS No.10416-59-8
Chemical FormulaC8H21NOSi2
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 52 (Arprinocide) structure
52
阿德福韦杂质52 (阿普西特)Adefovir Impurity 52 (Arprinocide)
Adefovir Impurity 52 (Arprinocide)
CAS No.55779-18-5
Chemical FormulaC12H9ClFN5
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 54 structure
54
阿德福韦杂质54Adefovir Impurity 54
Adefovir Impurity 54
CAS No.938-55-6
Chemical FormulaC7H9N5
Purity>95%询价On request
10mg25mg50mg100mg
Adefovir Impurity 7-d4 structure
7-D4
阿德福韦杂质7-d4Adefovir Impurity 7-d4
Adefovir Impurity 7-d4
CAS No.1189929-36-9
Chemical FormulaC12H16D4N5O4P
Purity>95%询价On request
Adefovir Impurity 43-d4 structure
43-D4
阿德福韦杂质43-d4Adefovir Impurity 43-d4
Adefovir Impurity 43-d4
CAS No.1346603-65-3
Chemical FormulaC8H9D4N5O7P2·n(C6H15N)
Purity>95%询价On request
Adefovir Impurity 44-d4 structure
44-D4
阿德福韦杂质44-d4Adefovir Impurity 44-d4
Adefovir Impurity 44-d4
CAS No.1346604-40-7
Chemical FormulaC8H10D4N5O10P3·n(C6H15N)
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿德福韦 —— 研究文献与合成路线Adefovir — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿德福韦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Adefovir. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation
    Lin RZ, Sun PJ, Tao Q, et al. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2016 · 被引 12cited 12
  2. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals
    Gao Y, Gao J, Liu Z, et al. · International journal of pharmaceutics · 2012 · 被引 35cited 35
  3. Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
    Gong X, Kong P, Yu T, et al. · Experimental hematology & oncology · 2022 · 被引 4cited 4
  4. Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution
    Oliyai R, Yuan LC, Dahl T · Nucleosides, nucleotides & nucleic acids · 2001 · 被引 3cited 3
  5. [Determination of adefovir dipivoxil and its degradation products by reversed-phase high performance liquid chromatography]
    Jiang Y, Xu Z, Zhang X · Se pu = Chinese journal of chromatography · 2004 · 被引 1cited 1
  6. A Simple and Specific Stability- Indicating RP-HPLC Method for Routine Assay of Adefovir Dipivoxil in Bulk and Tablet Dosage Form
    Darsazan B, Shafaati A, Mortazavi SA, et al. · Iranian journal of pharmaceutical research : IJPR · 2017 · 被引 1cited 1

合成与制备工艺专利Synthesis & process patents

  1. Synthesis process of adefovir dipivoxil raw medicine
    KAICHAO LIN, CHENGJIE LIU, HUABEI ZONG · 公开号 CN101830932CN101830932 · 2010
  2. METHOD FOR PREPARING CRYSTALLINE ADEFOVIR DIPIVOXIL AND ADEFOVIR DIPIVOXIL BUTANOLATE USED THEREIN
    OH HEE SOOK, BYUN EUN YOUNG, JANG SUK MAN, HA TAE HEE, et al. · 公开号 WO2010120074WO2010120074 · 2010
  3. PREPARATION METHOD OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, ADEFOVIR DIPIVOXIL AND AMORPHOUS ADEFOVIR DIPIVOXIL
    KWON WOONG, LEE JAE HYOUNG · 公开号 KR20110038780KR20110038780 · 2011
  4. NOVEL CRYSTAL FORMS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARING THE SAME
    CHOI SOO JIN, LEE BYUNG GOO, OH SEONG SOO, KIM YONG TAE, et al. · 公开号 EP2411392EP2411392 · 2012
  5. NOVEL CRYSTAL FORMS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARING THE SAME
    CHOI SOO JIN, LEE BYUNG GOO, OH SEONG SOO, KIM YONG TAE, et al. · 公开号 US2012101273US2012101273 · 2012

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿德福韦 杂质谱研究要点Adefovir — impurity profiling notes

下面这些是拿到 阿德福韦 的 49 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 49 impurity entries for Adefovir, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances